<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    Sophiris Bio, Inc.

    verified_userVerify Profile
    Companies » Health Care » Pharmaceuticals & Biotechnology » Pharmaceuticals

    About Sophiris Bio, Inc.

    Sophiris Bio Inc. is a late-stage biopharmaceutical company developing topsalysin (PRX302) for the treatment of patients with urological diseases. Topsalysin is in Phase 2 clinical development for the focal treatment of localized prostate cancer as well as Phase 3 clinical development for the treatment of lower urinary tract symptoms of benign prostatic hyperplasia (BPH). Source

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      NASDAQ
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $80,700,000
    • SIC CODE
      2834
    • NIN CODE
      ####
    • LEADERSHIP
      Randall E. Woods
    • FOUNDED
      2002
    • EMPLOYEES
      0-10
    • SECTOR
      Pharmaceuticals & Biotechnology
    • SUBSECTOR
      Pharmaceuticals

    Company Tags

    No articles found.

    AxoGen, Inc.

    AxoGen, Inc.

    Axogen (AXGN) is a global leader in innovative surgical solutions for peripheral n...

    Axogen (AXGN) is a global leader in innovative ...

    Filing Type:    PU
    Organovo Holdings, Inc.

    Organovo Holdings, Inc.

    Organovo is a biotech platform company that has developed a leadership position wi...

    Organovo is a biotech platform company that has...

    Filing Type:    PU
    G1 Therapeutics, Inc.

    G1 Therapeutics, Inc.

    G1 Therapeutics, Inc., is a clinical-stage biopharmaceutical company focused on th...

    G1 Therapeutics, Inc., is a clinical-stage biop...

    Filing Type:    PU
    Milestone Pharmaceuticals Inc.

    Milestone Pharmaceuticals Inc.

    We are a patient-centric, clinical-stage biopharmaceutical company dedicated to br...

    We are a patient-centric, clinical-stage biopha...

    Filing Type:    PU
    CNS Pharmaceuticals, Inc

    CNS Pharmaceuticals, Inc

    CNS Pharmaceuticals is a pre-clinical stage biotechnology company specializing in ...

    CNS Pharmaceuticals is a pre-clinical stage bio...

    Amount Raised:    $628,558
    Fundraising Status:    EC
    Filing Type:    CF
    G1 Therapeutics, Inc.

    G1 Therapeutics, Inc.

    G1 Therapeutics, Inc., is a clinical-stage biopharmaceutical company focused on th...

    G1 Therapeutics, Inc., is a clinical-stage biop...

    Filing Type:    PU
    Prothena Corporation plc

    Prothena Corporation plc

    Prothena Corporation plc (Nasdaq: PRTA) is a clinical-stage neuroscience company f...

    Prothena Corporation plc (Nasdaq: PRTA) is a cl...

    Filing Type:    PU
    WAVE Life Sciences Ltd.

    WAVE Life Sciences Ltd.

    We are a biotechnology company focused on delivering transformational therapies fo...

    We are a biotechnology company focused on deliv...

    Filing Type:    PU
    Osmotica Pharmaceuticals plc

    Osmotica Pharmaceuticals plc

    Osmotica Pharmaceuticals plc is a fully-integrated biopharmaceutical company focus...

    Osmotica Pharmaceuticals plc is a fully-integra...

    Filing Type:    PU
    ©2025 National Investor Network. All Rights Reserved.